CX3CR1 and prostate cancer: In addition, we have shown that CX3CR1 is expressed in a high percentage of prostate cancer tissues while human bone marrow supernatants contain soluble FKN, which is released from cells of the bone stroma through a mechanism regulated by androgens [20].